LLBO doesn't have a Product, Interesting or Otherwise.
KATX is no longer an exploration company and LLBO is no longer a biotech. Acropolis is turning them into shells, like KAST. IF a private company buys them to reverse merge into, THAT is what they will become.
The whole point is: KAST is far more attractive reverse merger candidate. If Acropolis can't sell KAST, it's EXTREMELY unlikely they will be able to sell LLBO or KATX.
News 
Market Data 
Discover 
